IND for COVID-19 with Opaganib Submitted to the FDA by RedHill Biopharma | Small Molecules | News Channels - PipelineReview.com

IND for COVID-19 with Opaganib Submitted to the FDA by RedHill Biopharma | Small Molecules | News Channels  PipelineReview.com